Logo
dora @dora
Precise antibody sequencing without reference genome requirements using our proprietary multi-enzymatic digestion and advanced MS/MS fragmentation techniques. We determine complete heavy and light chain amino acid sequences with coverage of CDRs and framework regions. Essential for therapeutic antibody development, hybridoma cell line authentication, biosimilar characterization, and intellectual property protection. Creative Proteomics provides comprehensive sequence reports with confidence scores and post-translational modification mapping to support your antibody engineering efforts. https://www.creative-prote...
09:50 AM - May 23, 2025 (UTC)

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from dora , click on at the bottom under it